ZK / BTC

ZK / USDC

ZK / FDUSD

ZK / TRY

ZK / USDT

ZEN / USDC

DASH / ETH

DASH / USDT

ZEN / USDT

DASH / BTC

DENT / ETH

ASR / USDT

ASR / TRY

VELODROME / USDC

VET / BTC

SKL / BTC

HEMI / BNB

DOLO / FDUSD

YB / BNB

DOLO / USDC

RENOL POLYCHEM LIMITED

LAKSHYA POWERTECH LIMITED

MUFIN GREEN FINANCE LTD

LANCOR HOLDINGS LIMITED

EUROTEX IND & EXPORTS LTD

KONTOR SPACE LIMITED

THE GROB TEA COMPANY LTD

NAVIN FLUORINE INT. LTD

JAY BEE LAMINATIONS LTD

DIGIKORE STUDIOS LIMITED

FINEOTEX CHEMICAL LIMITED

ELPHI WORLD MONEY LTD

QUADRANT FUTURE TEK LTD

SIL INVESTMENTS LIMITED

NIRAJ ISPAT IND LTD

BANDHAN BANK LIMITED

MAAN ALUMINIUM LIMITED

NELCAST LIMITED

GLOBE INTL CARRIERS LTD

BANARAS BEADS LTD

Click here to get full coverage on Zota Health Care Announces Investor Meetings in Mumbai - TipRanks

Zota Health Care Announces Investor Meetings in Mumbai  TipRanks

Zota Health Care Announces Investor Meetings in Mumbai - TipRanks

Click here to get full coverage on Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update - Neurology Live

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update  Neurology Live

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update - Neurology Live

Click here to get full coverage on Zota: How Gateway Technology Unifies Global Payments - FinTech Magazine

Zota: How Gateway Technology Unifies Global Payments  FinTech Magazine

Zota: How Gateway Technology Unifies Global Payments - FinTech Magazine

Click here to get full coverage on Suspected gunman accused in 2017 double murder at Longboat Key’s Zota Beach Resort charged - FOX 13 Tampa Bay

Suspected gunman accused in 2017 double murder at Longboat Key’s Zota Beach Resort charged  FOX 13 Tampa Bay

Suspected gunman accused in 2017 double murder at Longboat Key’s Zota Beach Resort charged - FOX 13 Tampa Bay

Click here to get full coverage on Third suspect charged in 2017 Zota Beach Resort double-homicide - ABC7 WWSB

Third suspect charged in 2017 Zota Beach Resort double-homicide  ABC7 WWSB

Third suspect charged in 2017 Zota Beach Resort double-homicide - ABC7 WWSB

Click here to get full coverage on Gunman in Longboat Key Zota murders arrested after 2017 shooting, police say - Bradenton Herald

Gunman in Longboat Key Zota murders arrested after 2017 shooting, police say  Bradenton Herald

Gunman in Longboat Key Zota murders arrested after 2017 shooting, police say - Bradenton Herald

Click here to get full coverage on Novartis to buy Avidity and its neuromuscular RNA pipeline for $12B - FirstWord Pharma

Novartis to buy Avidity and its neuromuscular RNA pipeline for $12B  FirstWord Pharma

Novartis to buy Avidity and its neuromuscular RNA pipeline for $12B - FirstWord Pharma

Click here to get full coverage on Patients With DMD Treated With Avidity Biosciences’ Antibody-Oligonucleotide Conjugate Del-Zota Show Functional Improvements - CGTLive®

Patients With DMD Treated With Avidity Biosciences’ Antibody-Oligonucleotide Conjugate Del-Zota Show Functional Improvements  CGTLive®

Patients With DMD Treated With Avidity Biosciences’ Antibody-Oligonucleotide Conjugate Del-Zota Show Functional Improvements - CGTLive®

Click here to get full coverage on Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients - Clinical Trials Arena

Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients  Clinical Trials Arena

Avidity’s del-zota elicits 25% increase in dystrophin in DMD patients - Clinical Trials Arena

Click here to get full coverage on Del-zota for DMD awarded FDA breakthrough therapy designation - Muscular Dystrophy News

Del-zota for DMD awarded FDA breakthrough therapy designation  Muscular Dystrophy News

Del-zota for DMD awarded FDA breakthrough therapy designation - Muscular Dystrophy News

Click here to get full coverage on Will FDA Feedback and Del-Zota BLA Timeline Shift Redefine Avidity Biosciences' (RNA) Late-Stage Pipeline? - Yahoo Finance

Will FDA Feedback and Del-Zota BLA Timeline Shift Redefine Avidity Biosciences' (RNA) Late-Stage Pipeline?  Yahoo Finance

Will FDA Feedback and Del-Zota BLA Timeline Shift Redefine Avidity Biosciences' (RNA) Late-Stage Pipeline? - Yahoo Finance

Click here to get full coverage on Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip - PR Newswire

Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip  PR Newswire

Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skip - PR Newswire

Click here to get full coverage on Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases - British Pharmacological Society | Journals

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases  British Pharmacological Society | Journals

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases - British Pharmacological Society | Journals

Click here to get full coverage on Q1 2026 BLA Planned: Avidity's Breakthrough Therapy del‑zota Receives Positive FDA Pre‑BLA Guidance - Stock Titan

Q1 2026 BLA Planned: Avidity's Breakthrough Therapy del‑zota Receives Positive FDA Pre‑BLA Guidance  Stock Titan

Q1 2026 BLA Planned: Avidity's Breakthrough Therapy del‑zota Receives Positive FDA Pre‑BLA Guidance - Stock Titan

Click here to get full coverage on Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD - Neurology Live

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD  Neurology Live

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD - Neurology Live

Click here to get full coverage on Exon-skipping therapy shows promise for DMD44 - Muscular Dystrophy News

Exon-skipping therapy shows promise for DMD44  Muscular Dystrophy News

Exon-skipping therapy shows promise for DMD44 - Muscular Dystrophy News

Click here to get full coverage on Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Del-Zota for Duchenne Muscular Dystrophy  CGTLive®

Del-Zota for Duchenne Muscular Dystrophy - CGTLive®

Click here to get full coverage on Zota Health Care Releases Unaudited Financial Results - TipRanks

Zota Health Care Releases Unaudited Financial Results  TipRanks

Zota Health Care Releases Unaudited Financial Results - TipRanks

Click here to get full coverage on Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025 - TipRanks

Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025  TipRanks

Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025 - TipRanks

Click here to get full coverage on Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy - Neurology Live

Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy  Neurology Live

Michael Flanagan, PhD, on Del-zota’s Breakthrough Potential for Duchenne Muscular Dystrophy - Neurology Live

Click here to get full coverage on Avidity reports positive pre-BLA meeting on Duchenne muscular dystrophy asset del-zota - MSN

Avidity reports positive pre-BLA meeting on Duchenne muscular dystrophy asset del-zota  MSN

Avidity reports positive pre-BLA meeting on Duchenne muscular dystrophy asset del-zota - MSN

Click here to get full coverage on Zota Beach Resort sets the scene for local business connections - Your Observer

Zota Beach Resort sets the scene for local business connections  Your Observer

Zota Beach Resort sets the scene for local business connections - Your Observer

Click here to get full coverage on Suspect arrested in 2017 Zota Beach Resort double murder - WFLA

Suspect arrested in 2017 Zota Beach Resort double murder  WFLA

Suspect arrested in 2017 Zota Beach Resort double murder - WFLA

Click here to get full coverage on Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44 - Yahoo Finance

Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44  Yahoo Finance

Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44 - Yahoo Finance

Click here to get full coverage on Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44 - Neurology Live

Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44  Neurology Live

Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44 - Neurology Live

Click here to get full coverage on Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society - Yahoo Finance

Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society  Yahoo Finance

Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society - Yahoo Finance

Click here to get full coverage on One more suspect charged in 2017 Longboat Key homicide case - Your Observer

One more suspect charged in 2017 Longboat Key homicide case  Your Observer

One more suspect charged in 2017 Longboat Key homicide case - Your Observer

Click here to get full coverage on Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-Zota - Seeking Alpha

Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-Zota  Seeking Alpha

Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-Zota - Seeking Alpha

Click here to get full coverage on Avidity Biosciences Updates BLA Submission Timeline for Del-Zota - TradingView

Avidity Biosciences Updates BLA Submission Timeline for Del-Zota  TradingView

Avidity Biosciences Updates BLA Submission Timeline for Del-Zota - TradingView

Click here to get full coverage on Avidity Biosciences reports positive one-year data for del-zota in DMD44 trials - Drug Discovery News

Avidity Biosciences reports positive one-year data for del-zota in DMD44 trials  Drug Discovery News

Avidity Biosciences reports positive one-year data for del-zota in DMD44 trials - Drug Discovery News

Click here to get full coverage on Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026 - Yahoo Finance

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026  Yahoo Finance

Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026 - Yahoo Finance

Click here to get full coverage on Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA - BioSpace

Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA  BioSpace

Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA - BioSpace

Click here to get full coverage on Zota Health Care Ltd. Expands Davaindia Store Network in Q2FY26 - TipRanks

Zota Health Care Ltd. Expands Davaindia Store Network in Q2FY26  TipRanks

Zota Health Care Ltd. Expands Davaindia Store Network in Q2FY26 - TipRanks

Click here to get full coverage on Man arrested 8 years after double homicide at Longboat Key resort - wtsp.com

Man arrested 8 years after double homicide at Longboat Key resort  wtsp.com

Man arrested 8 years after double homicide at Longboat Key resort - wtsp.com

Click here to get full coverage on Zota Health Care Ltd. Increases Equity Capital Through Warrant Conversion - TipRanks

Zota Health Care Ltd. Increases Equity Capital Through Warrant Conversion  TipRanks

Zota Health Care Ltd. Increases Equity Capital Through Warrant Conversion - TipRanks

Click here to get full coverage on Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society - Investing News Network

Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society  Investing News Network

Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society - Investing News Network

Click here to get full coverage on Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025 - MSN

Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025  MSN

Zota Health Care Ltd. Complies with SEBI Regulations for Q3 2025 - MSN

Click here to get full coverage on Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update - FirstWord Pharma

Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update  FirstWord Pharma

Avidity's exon-skipping therapy shows dystrophin gains in Duchenne trial update - FirstWord Pharma

Click here to get full coverage on Avidity stock rises after del-zota shows disease reversal in DMD44 trial - Investing.com

Avidity stock rises after del-zota shows disease reversal in DMD44 trial  Investing.com

Avidity stock rises after del-zota shows disease reversal in DMD44 trial - Investing.com

Click here to get full coverage on Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping - Yahoo Finance

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping  Yahoo Finance

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping - Yahoo Finance

Click here to get full coverage on Why Avidity Biosciences (RNA) Rose After $600M Equity Raise and Positive Del-zota Trial Results - Sahm

Why Avidity Biosciences (RNA) Rose After $600M Equity Raise and Positive Del-zota Trial Results  Sahm

Why Avidity Biosciences (RNA) Rose After $600M Equity Raise and Positive Del-zota Trial Results - Sahm

Click here to get full coverage on Avidity granted FDA Breakthrough status for DMD therapy - The Pharma Letter

Avidity granted FDA Breakthrough status for DMD therapy  The Pharma Letter

Avidity granted FDA Breakthrough status for DMD therapy - The Pharma Letter

Click here to get full coverage on Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion - TipRanks

Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion  TipRanks

Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion - TipRanks

Click here to get full coverage on Reversal of disease progression after 1 year — Avidity's del-zota EXPLORE44 data at WMS Oct 7-11 - Stock Titan

Reversal of disease progression after 1 year — Avidity's del-zota EXPLORE44 data at WMS Oct 7-11  Stock Titan

Reversal of disease progression after 1 year — Avidity's del-zota EXPLORE44 data at WMS Oct 7-11 - Stock Titan

Click here to get full coverage on 25% Dystrophin Increase & 80% CK Reduction: Avidity's Del-zota Achieves Breakthrough in DMD44 Treatment - Stock Titan

25% Dystrophin Increase & 80% CK Reduction: Avidity's Del-zota Achieves Breakthrough in DMD44 Treatment  Stock Titan

25% Dystrophin Increase & 80% CK Reduction: Avidity's Del-zota Achieves Breakthrough in DMD44 Treatment - Stock Titan

Click here to get full coverage on FDA grants Breakthrough Therapy designation to Duchenne muscular dystrophy therapeutic - Drug Discovery News

FDA grants Breakthrough Therapy designation to Duchenne muscular dystrophy therapeutic  Drug Discovery News

FDA grants Breakthrough Therapy designation to Duchenne muscular dystrophy therapeutic - Drug Discovery News

Click here to get full coverage on Zota Health Care expands Davaindia network to 1,760 operational stores - Indian Pharma Post

Zota Health Care expands Davaindia network to 1,760 operational stores  Indian Pharma Post

Zota Health Care expands Davaindia network to 1,760 operational stores - Indian Pharma Post

Click here to get full coverage on Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst - Fierce Biotech

Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst  Fierce Biotech

Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst - Fierce Biotech

Click here to get full coverage on Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota - Insider Monkey

Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota  Insider Monkey

Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota - Insider Monkey

Click here to get full coverage on Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy - Managed Healthcare Executive

Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy  Managed Healthcare Executive

Promising Early Results of Investigational Duchenne Muscular Dystrophy Therapy - Managed Healthcare Executive

Click here to get full coverage on Avidity Biosciences Completes FDA Pre-BLA Meeting for Del-Zota, Targets 2026 Submission - MarketScreener

Avidity Biosciences Completes FDA Pre-BLA Meeting for Del-Zota, Targets 2026 Submission  MarketScreener

Avidity Biosciences Completes FDA Pre-BLA Meeting for Del-Zota, Targets 2026 Submission - MarketScreener

Click here to get full coverage on Zota Health Care reports consolidated net loss of Rs 15.95 crore in the September 2025 quarter - Business Standard

Zota Health Care reports consolidated net loss of Rs 15.95 crore in the September 2025 quarter  Business Standard

Zota Health Care reports consolidated net loss of Rs 15.95 crore in the September 2025 quarter - Business Standard

Click here to get full coverage on Zota Health Car Standalone September 2025 Net Sales at Rs 99.42 crore, up 68.49% Y-o-Y - Moneycontrol

Zota Health Car Standalone September 2025 Net Sales at Rs 99.42 crore, up 68.49% Y-o-Y  Moneycontrol

Zota Health Car Standalone September 2025 Net Sales at Rs 99.42 crore, up 68.49% Y-o-Y - Moneycontrol

Click here to get full coverage on Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues - simplywall.st

Investors Interested In Zota Health Care Limited's (NSE:ZOTA) Revenues  simplywall.st

ZOTA

Price Chart

Key Statistics

Technicals

About ZOTA

Latest News

Zota Health Care Announces Investor Meetings in Mumbai - TipRanks

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update - Neurology Live

Zota: How Gateway Technology Unifies Global Payments - FinTech Magazine

Advanced Charts

Top Gainers

Top Losers